Ignite Creation Date:
2025-12-24 @ 12:39 PM
Ignite Modification Date:
2026-02-01 @ 6:05 AM
Study NCT ID:
NCT01190761
Status:
COMPLETED
Last Update Posted:
2010-08-30
First Post:
2010-08-26
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Bioequivalence Study of Galantamine 4 mg Tablet and Reminyl Following a 4 mg Dose in Healthy Subjects Under Fed Conditions
Sponsor:
Actavis Inc.
Organization: